Human breast milk exosomes attenuate intestinal damage

Area of Science:

• Neonatal research
• Gastroenterology
• Biomedical science

Background:

• Human breast milk (HBM) contains exosomes that protect against necrotizing enterocolitis (NEC).
• Pasteurization of donor milk may compromise its beneficial components.
• This study examines the impact of raw and pasteurized HBM exosomes on intestinal inflammation.

Purpose of the Study:

• To evaluate the therapeutic potential of exosomes from raw and pasteurized HBM in mitigating intestinal inflammation.
• To compare the efficacy of raw versus pasteurized HBM-derived exosomes in preclinical models of NEC.

Main Methods:

• Exosomes were isolated from HBM and characterized using western blot, nanoparticle tracking analysis, and transmission electron microscopy.
• Mouse intestine organoids and in vivo NEC models (hypoxia, gavage feeding, LPS) were used to assess exosome effects.
• Statistical analysis involved one-way ANOVA with Bonferroni post-test.

Main Results:

• Both raw and pasteurized HBM exosomes demonstrated anti-inflammatory effects in organoid models.
• In vivo, HBM exosomes (both raw and pasteurized) ameliorated NEC-induced mucosal injury, inflammation, and mucus overproduction.
• No significant difference was observed in the efficacy of raw versus pasteurized HBM exosomes.

Conclusions:

• Exosomes from both raw and pasteurized human breast milk equally reduce intestinal damage in NEC models.
• The findings suggest exosome administration as a potential therapeutic strategy for NEC.
• Further clinical investigation is warranted to explore exosome application in patient care.